Literature DB >> 28691929

Biallelic mutations in the ubiquitin ligase RFWD3 cause Fanconi anemia.

Kerstin Knies1, Shojiro Inano2,3, María J Ramírez4,5, Masamichi Ishiai2, Jordi Surrallés4,5,6, Minoru Takata2, Detlev Schindler1.   

Abstract

The WD40-containing E3 ubiquitin ligase RFWD3 has been recently linked to the repair of DNA damage by homologous recombination (HR). Here we have shown that an RFWD3 mutation within the WD40 domain is connected to the genetic disease Fanconi anemia (FA). An individual presented with congenital abnormalities characteristic of FA. Cells from the patient carrying the compound heterozygous mutations c.205_206dupCC and c.1916T>A in RFWD3 showed increased sensitivity to DNA interstrand cross-linking agents in terms of increased chromosomal breakage, reduced survival, and cell cycle arrest in G2 phase. The cellular phenotype was mirrored in genetically engineered human and avian cells by inactivation of RFWD3 or introduction of the patient-derived missense mutation, and the phenotype was rescued by expression of wild-type RFWD3 protein. HR was disrupted in RFWD3-mutant cells as a result of impaired relocation of mutant RFWD3 to chromatin and defective physical interaction with replication protein A. Rfwd3 knockout mice appear to have increased embryonic lethality, are subfertile, show ovarian and testicular atrophy, and have a reduced lifespan resembling that of other FA mouse models. Although RFWD3 mutations have thus far been detected in a single child with FA, we propose RFWD3 as an FA gene, FANCW, supported by cellular paradigm systems and an animal model.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28691929      PMCID: PMC5531404          DOI: 10.1172/JCI92069

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Mcm8 and Mcm9 form a complex that functions in homologous recombination repair induced by DNA interstrand crosslinks.

Authors:  Kohei Nishimura; Masamichi Ishiai; Kazuki Horikawa; Tatsuo Fukagawa; Minoru Takata; Haruhiko Takisawa; Masato T Kanemaki
Journal:  Mol Cell       Date:  2012-07-05       Impact factor: 17.970

2.  Natural history and management of Fanconi anemia patients with head and neck cancer: A 10-year follow-up.

Authors:  David I Kutler; Krupa R Patel; Arleen D Auerbach; Jennifer Kennedy; Francis P Lach; Erica Sanborn; Marc A Cohen; William I Kuhel; Agata Smogorzewska
Journal:  Laryngoscope       Date:  2015-10-20       Impact factor: 3.325

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 4.  Fanconi anemia and the development of leukemia.

Authors:  Blanche P Alter
Journal:  Best Pract Res Clin Haematol       Date:  2014-10-15       Impact factor: 3.020

5.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

6.  RING finger and WD repeat domain 3 (RFWD3) associates with replication protein A (RPA) and facilitates RPA-mediated DNA damage response.

Authors:  Shangfeng Liu; Jessica Chu; Nur Yucer; Mei Leng; Shih-Ya Wang; Benjamin P C Chen; Walter N Hittelman; Yi Wang
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

7.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

8.  Preferential binding to branched DNA strands and strand-annealing activity of the human Rad51B, Rad51C, Rad51D and Xrcc2 protein complex.

Authors:  Hiroshi Yokoyama; Naoyuki Sarai; Wataru Kagawa; Rima Enomoto; Takehiko Shibata; Hitoshi Kurumizaka; Shigeyuki Yokoyama
Journal:  Nucleic Acids Res       Date:  2004-05-11       Impact factor: 16.971

9.  A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51.

Authors:  Najim Ameziane; Patrick May; Anneke Haitjema; Henri J van de Vrugt; Sari E van Rossum-Fikkert; Dejan Ristic; Gareth J Williams; Jesper Balk; Davy Rockx; Hong Li; Martin A Rooimans; Anneke B Oostra; Eunike Velleuer; Ralf Dietrich; Onno B Bleijerveld; A F Maarten Altelaar; Hanne Meijers-Heijboer; Hans Joenje; Gustavo Glusman; Jared Roach; Leroy Hood; David Galas; Claire Wyman; Rudi Balling; Johan den Dunnen; Johan P de Winter; Roland Kanaar; Richard Gelinas; Josephine C Dorsman
Journal:  Nat Commun       Date:  2015-12-18       Impact factor: 14.919

10.  Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

Authors:  Junko Murai; Shar-yin N Huang; Benu Brata Das; Amelie Renaud; Yiping Zhang; James H Doroshow; Jiuping Ji; Shunichi Takeda; Yves Pommier
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 13.312

View more
  78 in total

1.  PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors.

Authors:  Ilgin Cagnan; Erdal Cosgun; Ozlen Konu; Duygu Uckan; Aysen Gunel-Ozcan
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

2.  The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair.

Authors:  Fengshan Liang; Adam S Miller; Caroline Tang; David Maranon; Elizabeth A Williamson; Robert Hromas; Claudia Wiese; Weixing Zhao; Patrick Sung; Gary M Kupfer
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 3.  Fanconi anemia and the underlying causes of genomic instability.

Authors:  Julie Rageul; Hyungjin Kim
Journal:  Environ Mol Mutagen       Date:  2020-02-06       Impact factor: 3.216

4.  PCNA-mediated stabilization of E3 ligase RFWD3 at the replication fork is essential for DNA replication.

Authors:  Yo-Chuen Lin; Yating Wang; Rosaline Hsu; Sumanprava Giri; Susan Wopat; Mariam K Arif; Arindam Chakraborty; Kannanganattu V Prasanth; Supriya G Prasanth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-10       Impact factor: 11.205

Review 5.  Proteolytic control of genome integrity at the replication fork.

Authors:  Julie Rageul; Alexandra S Weinheimer; Jennifer J Park; Hyungjin Kim
Journal:  DNA Repair (Amst)       Date:  2019-07-10

6.  Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia.

Authors:  Christen L Ebens; Todd E DeFor; Rebecca Tryon; John E Wagner; Margaret L MacMillan
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-02       Impact factor: 5.742

7.  FANCD2 is required for the repression of germline transposable elements.

Authors:  Yan Nie; Andrew F Wilson; Tony DeFalco; Amom Ruhikanta Meetei; Satoshi H Namekawa; Qishen Pang
Journal:  Reproduction       Date:  2020-06       Impact factor: 3.906

8.  Fanconi Anemia: A Syndrome of Anemia and Skeletal Malformations Progressing to a Gene Network Involved in Genomic Stability and Malignant Disease.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2020-10-22

9.  Clinical and Molecular Characterization of Fanconi Anemia Patients in Turkey.

Authors:  Güven Toksoy; Dilek Uludağ Alkaya; Gülendam Bagirova; Şahin Avcı; Agharza Aghayev; Nilay Günes; Umut Altunoğlu; Yasemin Alanay; Seher Başaran; Ezgi G Berkay; Birsen Karaman; Tiraje T Celkan; Hilmi Apak; Hülya Kayserili; Beyhan Tüysüz; Zehra O Uyguner
Journal:  Mol Syndromol       Date:  2020-09-23

10.  Reduced Cell Division Control Protein 42 Activity Compromises Hematopoiesis-Supportive Function of Fanconi Anemia Mesenchymal Stromal Cells.

Authors:  Jian Xu; Xue Li; Allison Cole; Zachary Sherman; Wei Du
Journal:  Stem Cells       Date:  2018-02-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.